What is she best known for?
The fields of study she is best known for:
- Internal medicine
- Cancer
- Surgery
Ira M. Jacobson focuses on Internal medicine, Hepatitis C virus, Gastroenterology, Hepatitis C and Immunology.
Her study in Internal medicine is interdisciplinary in nature, drawing from both Surgery, Interferon, Ribavirin, Sofosbuvir and Placebo.
Her Hepatitis C virus study deals with the bigger picture of Virology.
Her work carried out in the field of Gastroenterology brings together such families of science as Hepatitis B, Biopsy, Liver biopsy, Pathology and Alpha interferon.
Her research on Hepatitis C also deals with topics like
- Faldaprevir that intertwine with fields like Pharmacology,
- Tolerability most often made with reference to Peginterferon alfa-2a.
Her work focuses on many connections between Immunology and other disciplines, such as Cirrhosis, that overlap with her field of interest in Odds ratio.
Her most cited work include:
- Telaprevir for Previously Untreated Chronic Hepatitis C Virus Infection (2132 citations)
- Sofosbuvir for previously untreated chronic hepatitis C infection (1448 citations)
- Ledipasvir and Sofosbuvir for Untreated HCV Genotype 1 Infection (1320 citations)
What are the main themes of her work throughout her whole career to date?
Internal medicine, Gastroenterology, Ribavirin, Virology and Hepatitis C virus are her primary areas of study.
Her research in Internal medicine intersects with topics in Chronic hepatitis and Sofosbuvir.
The Sofosbuvir study combines topics in areas such as Simeprevir, Ledipasvir and Voxilaprevir.
Her Gastroenterology study incorporates themes from Therapy naive, Regimen, Surgery, Peginterferon alfa-2a and Adverse effect.
The concepts of her Ribavirin study are interwoven with issues in Interferon and Viral load.
Immunology and Virus are the two main areas of interest in her Hepatitis C virus studies.
She most often published in these fields:
- Internal medicine (60.28%)
- Gastroenterology (42.12%)
- Ribavirin (39.12%)
What were the highlights of her more recent work (between 2016-2021)?
- Internal medicine (60.28%)
- Gastroenterology (42.12%)
- Hepatitis C virus (27.74%)
In recent papers she was focusing on the following fields of study:
Ira M. Jacobson mainly investigates Internal medicine, Gastroenterology, Hepatitis C virus, Hepatitis C and Sofosbuvir.
In the field of Internal medicine, her study on Cirrhosis, Adverse effect and Regimen overlaps with subjects such as In patient.
Her work deals with themes such as Viremia, Dasabuvir, Paritaprevir and Viral load, which intersect with Gastroenterology.
Her Hepatitis C virus study is within the categories of Virology and Immunology.
Her work investigates the relationship between Hepatitis C and topics such as Glecaprevir that intersect with problems in Randomized controlled trial.
The various areas that Ira M. Jacobson examines in her Sofosbuvir study include Velpatasvir, Ledipasvir, Voxilaprevir and Surgery.
Between 2016 and 2021, her most popular works were:
- Nonalcoholic Steatohepatitis Is the Fastest Growing Cause of Hepatocellular Carcinoma in Liver Transplant Candidates (201 citations)
- Efficacy of 8 Weeks of Sofosbuvir, Velpatasvir, and Voxilaprevir in Patients With Chronic HCV Infection: 2 Phase 3 Randomized Trials (159 citations)
- Efficacy of 8 Weeks of Sofosbuvir, Velpatasvir, and Voxilaprevir in Patients With Chronic HCV Infection: 2 Phase 3 Randomized Trials (159 citations)
In her most recent research, the most cited papers focused on:
- Internal medicine
- Cancer
- Surgery
Ira M. Jacobson mostly deals with Internal medicine, Hepatitis C virus, Sofosbuvir, Gastroenterology and Hepatitis C.
Her Internal medicine research incorporates elements of Chronic hepatitis and Metabolic syndrome.
Ira M. Jacobson works in the field of Hepatitis C virus, focusing on Ribavirin in particular.
Her Ribavirin course of study focuses on Interferon and Direct acting, Multivariate analysis, Antiviral therapy and Quality of life.
Her Sofosbuvir research is multidisciplinary, incorporating perspectives in Pibrentasvir, Clinical trial, Surgery, Glecaprevir and Voxilaprevir.
Her studies deal with areas such as Ledipasvir, Adverse effect and NS5A as well as Gastroenterology.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
